0001209191-20-001775.txt : 20200106 0001209191-20-001775.hdr.sgml : 20200106 20200106161852 ACCESSION NUMBER: 0001209191-20-001775 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200106 DATE AS OF CHANGE: 20200106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YOUNG WILLIAM D CENTRAL INDEX KEY: 0001217420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20509935 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001217420 YOUNG WILLIAM D C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2020-01-02 4 M 0 20000 72.14 A 29311 D Common Stock 2020-01-02 4 S 0 2500 217.72 D 26811 D Common Stock 2020-01-02 4 S 0 7266 218.73 D 19545 D Common Stock 2020-01-02 4 S 0 10134 219.37 D 9411 D Common Stock 2020-01-02 4 S 0 100 220.08 D 9311 D Stock Option (Right to Buy) 72.14 2020-01-02 4 M 0 20000 0.00 D 2024-05-31 Common Stock 20000 0 D Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $217.72 (range $217.08 to $218.06). Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $218.73 (range $218.08 to $219.07). Open market sales reported on this line occurred at a weighted average price of $219.37 (range $219.08 to $219.78). Fully vested. /s/ Omar White, Attorney-in-Fact 2020-01-06